Source: GlobalNewswire

Press Release: Entasis : Entasis Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Conference in London

WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer, will present at the H.C, Wainwright & Co. Global Life Sciences Conference being held April 7-9, 2019 in London, UK.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Manos Perros's photo - President & CEO of Entasis Therapeutics Holdings, Inc.

President & CEO

Manos Perros

CEO Approval Rating


Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more